MDXG - ミメディックス・グル―プ （MiMedx Group Inc） ミメディックス・グル―プMDXGのチャート
MDXGの企業情報
| symbol | MDXG |
|---|---|
| 会社名 | MiMedx Group Inc （ミメディックス・グル―プ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ミメックス・グループ(MiMedx Group Inc.)は再生バイオ材料製品およびバイオインプラントヒト胎盤組織、皮膚および骨の統合された開発・加工・販売に従事する。再生医療材料セグメントには、創傷ケア、外科手術、スポーツ医学、眼科および歯科の市場カテゴリーのための製品および組織処理サービスの設計・製造・販売が含まれる。その生体材料プラットフォーム技術には、「AmnioFix」、「EpiFix」、「OrthoFlo」、「Physio」、「AlloBurn」、「CollaFix」などがある。「AmnioFix」と「EpiFix」は寄付された胎盤由来のヒト羊膜から加工されたその組織技術である。「OrthoFlo」は、同種の使用のための羊水由来同種移植片である。「Physio」は骨移植材料であり、骨組織にキャリアを添加していない。新しいブランド「CollaFix」は、修復を増強するために、筋骨格系組織の自然な構成、構造、および機械的特性を模倣するように設計されたコラーゲン繊維技術である。 ミメディックス・グル―プは米国のバイオ医療企業。再生生体材料製品とヒト羊膜を生体埋込処理された製品の開発、製造、販売に従事。寄贈された人間の胎盤を、様々な技術処理を通して羊膜を加工し、同種移植片を提供する。製品は創傷ケア、外科、スポ―ツ医学、眼科、歯科他、広範の医療分野で利用される。本社はジョ―ジア州。 MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, the cinoany has both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The company derives its products from human placental tissues and process these tissues using its proprietary processing methods, including the PURION® process. The company employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx has supplied over two million allografts, through both direct and consignment shipments. |
| 本社所在地 | 1775 West Oak Commons Court N.E. Marietta GA 30062 USA |
| 代表者氏名 | Charles R. Evans Charles R. Evans |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 770-651-9100 |
| 設立年月日 | 31229 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 690人 |
| url | www.mimedx.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mdxg |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 36.86000 |
| 終値（lastsale） | 5.48 |
| 時価総額（marketcap） | 608471104.04 |
| 時価総額 | 時価総額（百万ドル） 589.59520 |
| 売上高 | 売上高（百万ドル） 303.46800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 553.08220 |
| 当期純利益 | 当期純利益（百万ドル） 35.33400 |
| 決算概要 | 決算概要 BRIEF: For the nine months ended 30 September 2017 MiMedx Group Inc revenues increased 33% to $233.6M. Net income increased from $6.5M to $29.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Gain on divestiture increase from $0K to $4.3M (income) Amortization of intangible assets decrease of 23% to $1.5M (expense). |
MDXGのテクニカル分析
MDXGのニュース
MiMedx Group Q1 2023 Earnings Preview 2023/05/01 21:35:56 Seeking Alpha
MiMedx Group (MDXG) is scheduled to announce Q1 earnings results on Tuesday, May 2nd, after market close.The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is…
MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2 2023/04/18 12:00:00 GlobeNewswire
MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 after the market close on Tuesday, May 2, 2023. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 5:00 p.m. Eastern Time on the same day.
MiMedx CFO Carlson to leave company 2023/03/23 20:28:35 Seeking Alpha
MiMedx (MDXG) said Thursday Peter Carlson will step down as the company''s chief financial officer. The company has initiated a search for its next CFO.
Can you now get a good deal on MiMedx Group Inc.’s shares? 2023/03/07 12:16:00 US Post News
MiMedx Group Inc. (NASDAQ:MDXG) closed Monday at $4.26 per share, down from $4.42 a day earlier. While MiMedx Group Inc. has underperformed by -3.62%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MDXG fell by -15.14%, with highs and lows ranging from $5.20 to $2.43, whereas […]
MiMedx Group GAAP EPS of -$0.02, revenue of $74.38M 2023/02/28 22:00:20 Seeking Alpha
MiMedx Group press release (MDXG): Q4 GAAP EPS of -$0.02.Revenue of $74.38M (+10.4% Y/Y).
MiMedx Group, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:MDXG) 2022/11/02 22:46:58 Seeking Alpha
The following slide deck was published by MiMedx Group, Inc.
MiMedx Group GAAP EPS of -$0.09 in-line, revenue of $67.69M beats by $0.96M (NASDAQ:MDXG) 2022/11/02 20:51:35 Seeking Alpha
MiMedx Group press release (MDXG): Q3 GAAP EPS of -$0.09 in-line.Revenue of $67.69M (+7.3% Y/Y) beats by $0.96M.The company expects net sales for the fourth quarter 2022 to be in a…
MIMEDX Announces Third Quarter 2022 Operating and Financial Results 2022/11/02 20:15:00 GlobeNewswire
Third Quarter Net Sales of $67.7 Million Reflect Growth of 7.3%
MiMedx Group Q3 2022 Earnings Preview 2022/11/01 21:35:59 Seeking Alpha
MiMedx Group (MDXG) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, after market close.The consensus EPS Estimate is -$0.12 (-200.0% Y/Y) and the consensus…
MiMedx Group Inc. (NASDAQ:MDXG) Stock Plunged -54.64% So Far In 2022, What Analysts Expect Next? 2022/09/24 12:30:00 Marketing Sentinel
In last trading session, MiMedx Group Inc. (NASDAQ:MDXG) saw 0.5 million shares changing hands with its beta currently measuring 1.77. Company’s recent per share price level of $2.74 trading at -$0.1 or -3.52% at ring of the bell on the day assigns it a market valuation of $328.47M. That closing price of MDXG’s stock is … MiMedx Group Inc. (NASDAQ:MDXG) Stock Plunged -54.64% So Far In 2022, What Analysts Expect Next? Read More »
MiMedx Group Inc. (NASDAQ:MDXG) Stock Plunged -54.64% So Far In 2022, What Analysts Expect Next? 2022/09/24 12:30:00 Marketing Sentinel
In last trading session, MiMedx Group Inc. (NASDAQ:MDXG) saw 0.5 million shares changing hands with its beta currently measuring 1.77. Company’s recent per share price level of $2.74 trading at -$0.1 or -3.52% at ring of the bell on the day assigns it a market valuation of $328.47M. That closing price of MDXG’s stock is … MiMedx Group Inc. (NASDAQ:MDXG) Stock Plunged -54.64% So Far In 2022, What Analysts Expect Next? Read More »
MIMEDX Announces Launch of AXIOFILL™ 2022/09/20 12:00:00 GlobeNewswire
Adds a Unique Collagen Matrix Particulate Derived from Human-Placental Tissue to the Growing $1B Surgical Recovery Market
MIMEDX Announces Launch of AMNIOEFFECT 2022/09/19 11:00:00 Wallstreet:Online
New Product Enables Company to Target Additional Surgical Procedures and Deepen Market Penetration in the Growing $1B Surgical Recovery Market MARIETTA, Ga., Sept. 19, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced the launch of AMNIOEFFECT, a tri-layer PURION processed human tissue
MDXG, EOSE and BORR among pre market gainers 2022/09/14 12:55:53 Seeking Alpha
Aditxt ADTX +73% after completing 1-for-50 reverse stock split.Eos Energy Enterprises (EOSE) +11%. RVL Pharmaceuticals (RVLP) +8%. MiMedx Group (MDXG) +7%. Borr Drilling (BORR) +6%
Nikola, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Today''s Pre-Market Session 2022/09/14 11:22:55 Benzinga
U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session. MAG Silver Corp. (NYSE: MAG ) rose 8.5% to $13.78 in pre-market trading after declining around 6% on Tuesday. The company, last month, posted a rise in quarterly earnings. MiMedx Group, Inc. (NASDAQ: MDXG ) gained 5.5% to $3.65 in pre-market trading. MiMedx Group recently said that EPIFIX received reimbursement approval in Japan. Nikola Corporation (NASDAQ: … Full story available on Benzinga.com